Skip to content

Study-aware participant-level pooled analysis

Joint analysis of comparable participant records from multiple studies while accounting for their study of origin.

Version
v1 · 2026-10-17 · History
Domain-specific #
14243
Domain group
Applied Sciences & Engineering
Origin domain
Medicine & Healthcare
Subdomain
Individual Participant Data Synthesis → Medicine & Healthcare

Core Idea

Study-aware participant-level pooled analysis jointly analyzes records about individual people from at least two source studies for a common research question. The analyst first establishes that variables used for that question can be interpreted together, then estimates the relation across participants while retaining which study supplied each record. The common data file alone does not supply the method: the variable meanings and study-origin handling make the combined estimate interpretable.[1][2]

This qualified title names a collective-data subtype. Authors also use the bare phrase pooled analysis for procedures that analyze each study separately and then combine its estimates. Conversely, a one-stage individual participant data (IPD) meta-analysis can be this subtype. The distinction is the operation performed on participant records, not a universal vocabulary split between pooling and meta-analysis.[1][3][2]

Structural Signature

  • Independent source studies and participant records. At least two studies supply person-level observations. A list of published effect estimates is a different input, even if the resulting paper reports a pooled number.
  • A common inferential target and comparable variables. The studies must support a question whose relevant treatment or exposure, outcome, and other model variables have defensible meanings across records. This may require harmonization; it does not require identical protocols, eligibility criteria, or populations.
  • Collective participant-level estimation. The records enter a joint analysis for the common relation. Its model family depends on the question and source designs; neither Cox nor logistic regression is universal.
  • Source-study handling. Each record's origin remains available to the analysis, which represents source clustering or differences as appropriate. Erasing source labels and fitting one unstratified model can exaggerate precision or mask differences.[1][2]

These roles describe the admitted collective-data subtype. The reviewed examples jointly analyze person-level data while retaining source-study information; their evidence does not establish a federated pooled-analysis instance. Federated analysis is a neighboring way to analyze distributed participant data and requires its own method boundary.[1]

What It Is Not

An analysis of published study summaries alone lacks the individual observations needed for this subtype. A two-stage IPD synthesis may reanalyze original records but then combine study-specific coefficients; it shares the broad pooled analysis label in some papers, yet its collective step is different. Smith-Warner and colleagues explicitly describe primary cohort data standardized within studies, study-specific Cox estimates, and subsequent random- or mixed-effects pooling. That is a boundary example, not a failed study.[3][1]

The method is also not an instruction to pretend that all participants came from one homogeneous mega-study. Designs, measurement systems, recruitment, and background risks can differ. Study membership is a source of structure to model or test, rather than noise to delete. Nor does access to more people guarantee a less biased or more precise answer if the question-relevant variables or analysis are incompatible.[1][2]

Scope of Application

The operation is used when multiple clinical or epidemiologic studies have participant records that can address a shared question. In randomized trials, a joint analysis can compare treatment groups across trials while allowing for trial origin. In observational case-control research, it can estimate an exposure-disease relation after constructing comparable exposure and outcome variables and adjusting for the contributing study.[4][5]

The admissible scope is set by the common question, record-level access, variable comparability, and source-study handling. Trials may differ in duration or dose; observational studies may differ in geography and sampling. These differences are not automatically disqualifying, but they must not be made invisible by the pooling operation.[4][5][1]

Clarity

The abstraction separates having more records from having a defensible common estimate. Harmonization concerns what a variable means in each source. Modeling source study concerns how those records are grouped or differ after harmonization. A harmonized outcome does not remove study-level clustering, and a study indicator cannot repair an outcome whose categories never meant the same thing.[1][2]

It also separates two senses of pooled: combining participants in a joint analysis and combining already estimated study results. Both can be called pooled in published work. Naming the qualified subtype prevents a terminological argument from hiding the actual analytic step.[1][3]

Manages Complexity

Several studies can differ in terminology, variable coding, timing, and baseline composition. A shared question and explicit cross-study variable mapping compress those differences into a tractable analysis without claiming they disappeared. Ross and colleagues reconciled adverse-event terms from two reporting vocabularies before constructing a cardiovascular event outcome; Ge and colleagues applied one occupation-, period-, and region-sensitive job-exposure matrix to participants from multiple case-control studies.[4][5]

The pooled estimate then compresses many individual records into a common relation. Keeping study origin in the model limits what that compression discards. A single coefficient can be useful, but it should not be read as proof that every source population has the same effect or that all measurement differences were resolved.[2][1]

Abstract Reasoning

To assess a proposed pooled analysis, trace the information chain. What source studies supplied person-level records? Which treatment or exposure and outcome definitions were reconciled? What joint question and model were used? Where does the source-study label enter estimation? A claim to have pooled data without those answers leaves the central validity conditions unaudited.[1][2]

Counterfactuals sharpen the boundary. Replace the participant records with only published effect estimates and this qualified operation is no longer available. Analyze each source separately and average its coefficients, and the procedure becomes a two-stage neighbor. Keep the joint person-level file but strip the study identifiers, and the calculation may continue mechanically while losing a defense against clustering or hidden source differences.[1][3][2]

Knowledge Transfer

The four-role method transfers literally between randomized drug-safety trials and observational occupational case-control studies. The common inferential target, participant data, cross-source comparability, and study-aware joint estimation remain; the event vocabularies, exposure construction, and statistical models change. This transfer is useful when evaluating whether a new collaboration truly reanalyzes individual information or merely combines published results.[4][5]

It does not transfer an effect estimate or causal interpretation from one setting to another. A study-stratified Cox analysis of trial events and a study-adjusted logistic analysis of occupational histories instantiate the same method subtype, but they answer different scientific questions under different design assumptions.[4][5]

Examples

Randomized trials: rofecoxib safety

Ross and colleagues jointly analyzed subject-level data from placebo-controlled rofecoxib trials. The trials reported adverse events under two terminology systems, CRISP and MedDRA; the investigators reviewed the terms to construct a common cardiovascular thromboembolic outcome. They estimated event rates and relative risks with Cox models stratified by study, using exact methods for sparse arms and adding trial records cumulatively as they became available.[4]

Mapped back: the trials are the source studies; each subject's treatment and event data are the participant records; reconciled adverse-event terms support a common target; cumulative subject-level estimation is the joint analysis; trial stratification is the source-study handling. Trial durations and doses differed, so sameness of every protocol is not part of the mapping.

Observational studies: occupational silica and lung cancer

Ge and colleagues pooled participant occupational and smoking histories from 14 European and Canadian case-control studies. A common job-exposure matrix assigned silica exposure by occupation, period, and region. They estimated exposure-disease associations in logistic models and adjusted for the contributing study, alongside other covariates.[5]

Mapped back: the case-control projects are the source studies; case, control, occupational, and smoking histories are participant records; the shared exposure construction supports question-relevant comparability; pooled logistic estimation is the joint analysis; the study adjustment retains source-study handling. The design is unlike randomized treatment allocation, yet it fills the same method roles.

Structural Tensions

More records can help a question only when the compared variables support a common meaning.[1] Joint estimation can obscure study differences if origin is erased.[2] The reviewed sources establish these risks, but not a necessary opposed-choice trade-off unique to this subtype. These are conditions to check, not evidence that improving one role intrinsically worsens another. The practical diagnostic is to inspect the variable crosswalk and the model's treatment of source study before interpreting the pooled estimate.

Structural–Framed Character

The entry is structural within research synthesis: independent source records, question-relevant comparability, collective analysis, and provenance-aware estimation form a recognizable relation in unlike trial and case-control settings. Analyzing a different disease, treatment, or exposure does not create a new method identity when those roles remain intact. Conversely, changing from person-level joint estimation to a synthesis of published study coefficients changes a constitutive step.[4][5][1]

Evaluative weight: whether the variables are comparable and the joint estimate is credible demands judgment; the bare four-role relation is recognizable before judging whether one particular estimate is trustworthy. Human-practice dependence: people negotiate data access, reconcile coding systems, and choose models, but the method is not constituted by one institution's policy or a preferred team arrangement. Institutional origin and setting: the inspected guidance and examples concern collaborative clinical and epidemiologic research, where access to participant records and study protocols matters.[4][5][1] That evidence establishes an operating setting, not a historical origin claim. Vocabulary travel: pooling travels broadly, while participant records, source-study clustering, and one-stage estimation keep this identity in statistical research. Import versus recognition: the Ross trial and Ge case-control analyses are literal instances with the same four roles; calling an unrelated combination of resources a pooled analysis imports only an analogy.

Its character: a structural statistical method within a human-run research frame, whose all-instance identity requires comparable participant data, joint estimation, and study-origin handling rather than a shared disease, model family, or institution.

Structural Core vs. Domain Accent

The broad skeleton resembles aggregation and statistical inference: bring multiple observations to bear on a common question. The domain-specific core adds original participant records from distinct studies, explicit comparability of variables entering the question, a collective estimate, and a way to represent source-study structure.[1][2] Those additions determine whether the named method is present; they are not just examples of generic pooling.

This is not a Prime under its own title. The roles do not survive replacing research studies with arbitrary resource pools or social groups. The fact that both randomized and observational studies can instantiate it shows breadth inside statistical research, not substrate independence across unrelated domains. A bounded future-Prime question is whether a more general, study-independent structure of combining comparable observations while retaining source-group differences recurs literally across unrelated fields. This entry does not answer that question or assert a new Prime.

Statistical Inference and Aggregation are structural neighbors because the operation estimates from data and combines information. Combinatorial Meta-Analysis is a nearby domain-specific method concerned with recombinations of study subsets. Their common themes help compare methods, while the participant-record and source-study roles identify the present method's boundary.

Neighborhood in Abstraction Space

Study-aware participant-level pooled analysis sits in a sparse region of the domain-specific corpus (95th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Unclustered & Miscellaneous (2721 abstractions)

Nearest neighbors

Computed from structural-signature embeddings · 2026-10-17

Not to Be Confused With

  • Any use of the bare title pooled analysis. Published usage is broader than this qualified participant-level collective-data subtype.[3]
  • Published-estimate meta-analysis. It combines already reported study estimates without jointly reanalyzing the participant records; that is a different input and computation.[1]
  • Every IPD meta-analysis. Cochrane includes both one-stage collective and two-stage study-estimate routes; only a one-stage route satisfying these roles falls here.[2]
  • An unstratified mega-study. Concatenating records while ignoring their study of origin does not establish the study-aware operation.[2]

References

[1] Isabel Fortier et al., “Maelstrom Research Guidelines for Rigorous Retrospective Data Harmonization,” International Journal of Epidemiology 46(1), 103–115 (2017), printed p. 104, Introduction, and pp. 108–110, harmonization steps and Table 2. https://doi.org/10.1093/ije/dyw075 ; version of record https://pure.tue.nl/ws/files/72437527/dyw075.pdf registry ↩a ↩b ↩c ↩d ↩e ↩f ↩g ↩h ↩i ↩j ↩k ↩l ↩m ↩n ↩o ↩p ↩q

[2] Jayne F. Tierney, Lesley A. Stewart, and Mike Clarke (2024), “Individual participant data, Cochrane Handbook chapter 26 version 6.5,” in Cochrane Handbook for Systematic Reviews of Interventions, chapter 26, §§26.1.1, 26.3.1, 26.4.2; chapter last updated October 2019. Official chapter title is “Individual participant data.” https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-26 registry ↩a ↩b ↩c ↩d ↩e ↩f ↩g ↩h ↩i ↩j ↩k ↩l

[3] Stephanie A. Smith-Warner et al., “Methods for Pooling Results of Epidemiologic Studies, The Pooling Project of Prospective Studies of Diet and Cancer,” American Journal of Epidemiology 163(11), 1053–1064 (2006), original abstract, Methods. Published title uses a colon after “Studies.” https://doi.org/10.1093/aje/kwj127 registry ↩a ↩b ↩c ↩d ↩e

[4] Joseph S. Ross, David Madigan, Kevin P. Hill, David S. Egilman, Yongfei Wang, and Harlan M. Krumholz (2009), “Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data, Lessons for Post-Market Pharmaceutical Safety Surveillance,” Archives of Internal Medicine 169(21), 1976–1985, original author manuscript, pp. 2–4, “Data source,” “Main outcome measure,” and “Data analysis.” Published title uses a colon after “Data.” https://doi.org/10.1001/archinternmed.2009.394 ; full author manuscript https://pmc.ncbi.nlm.nih.gov/articles/PMC2830805/ registry ↩a ↩b ↩c ↩d ↩e ↩f ↩g ↩h

[5] Calvin Ge et al., “Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks, A Pooled Analysis of Case-Control Studies,” American Journal of Respiratory and Critical Care Medicine 202, 412–421 (2020), printed pp. 412–414, Abstract, “Study Population,” “Exposure Assessment,” and “Statistical Analysis.” Published title uses a colon after “Risks.” https://doi.org/10.1164/rccm.201910-1926OC ; original PDF https://dspace.library.uu.nl/bitstream/handle/1874/408764/rccm.201910_1926oc.pdf?sequence=1 registry ↩a ↩b ↩c ↩d ↩e ↩f ↩g ↩h